{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:43:05Z","timestamp":1789875785372,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803287"],"award-info":[{"award-number":["81803287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073605"],"award-info":[{"award-number":["82073605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2019201288"],"award-info":[{"award-number":["H2019201288"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2020201037"],"award-info":[{"award-number":["H2020201037"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008047","name":"Hebei University","doi-asserted-by":"publisher","award":["DXK202014"],"award-info":[{"award-number":["DXK202014"]}],"id":[{"id":"10.13039\/501100008047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.chroma.2023.463787","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T20:16:57Z","timestamp":1673295417000},"page":"463787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Honeycomb resin-based spin-column solid-phase extraction for efficient determination of alectinib and its metabolite in human urine"],"prefix":"10.1016","volume":"1690","author":[{"given":"Zihui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6087-4426","authenticated-orcid":false,"given":"Hongyuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2023.463787_bib0001","unstructured":"WHO, factsheets details on cancer, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer, (last time accessed: March 3, 2021)."},{"key":"10.1016\/j.chroma.2023.463787_bib0002","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.chroma.2023.463787_bib0003","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3390\/cancers13061476","article-title":"Immunotherapy for ALK-rearranged non-small cell lung cancer: challenges inform promising approaches","volume":"13","author":"Sankar","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.chroma.2023.463787_bib0004","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S1470-2045(15)00077-7","article-title":"Genomic alterations in lung adenocarcinoma","volume":"16","author":"Devarakonda","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.chroma.2023.463787_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.632256","article-title":"Beyond conventional: the new horizon of targeted therapy for the treatment of advanced non small cell lung cancer","volume":"11","author":"Tartarone","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.chroma.2023.463787_bib0006","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2147\/DDDT.S147499","article-title":"Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy","volume":"13","author":"Ali","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.chroma.2023.463787_bib0007","first-page":"35","article-title":"Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer","volume":"6","author":"Burns","year":"2015","journal-title":"Lung Cancer (Auckl)"},{"key":"10.1016\/j.chroma.2023.463787_bib0008","first-page":"5491","article-title":"Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer","volume":"9","author":"Guo","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.chroma.2023.463787_bib0009","first-page":"10039","article-title":"Revisiting a lower starting dose of alectinib in ALK-Positive non-small cell lung cancer","volume":"27","author":"Sacdalan","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.chroma.2023.463787_bib0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/sscp.202000104","article-title":"Identification, isolation, and structure elucidation of novel forced degradation products of alectinib hydrochloride","volume":"4","author":"Parmar","year":"2021","journal-title":"Sep. Sci. plus"},{"key":"10.1016\/j.chroma.2023.463787_bib0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00280-018-3597-5","article-title":"Exposure\u2013response analysis of alectinib in crizotinib-resistant ALK positive non-small cell lung cancer","volume":"82","author":"Morcos","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.chroma.2023.463787_bib0012","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/1078155220979048","article-title":"Applications and challenges in therapeutic drug monitoring of cancer treatment: a review","volume":"27","author":"Salman","year":"2021","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.chroma.2023.463787_bib0013","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/cancers13081966","article-title":"Systematic review and network meta-analysis of anaplastic lymphoma kinase (ALK) inhibitors for treatment-naive ALK-positive lung cancer","volume":"13","author":"Chuang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.chroma.2023.463787_bib0014","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/14740338.2016.1164690","article-title":"The use and risks of antibiotics in critically ill patients","volume":"15","author":"Denny","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.chroma.2023.463787_bib0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/14787210.2021.1851193","article-title":"Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients \u2013 the role of therapeutic drug monitoring","volume":"19","author":"Ho","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.chroma.2023.463787_bib0016","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clinbiochem.2016.12.008","article-title":"Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: a step towards home sampling","volume":"50","author":"Linder","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.chroma.2023.463787_bib0017","first-page":"117","article-title":"Immunosuppressant drug monitoring: a routine undertaking?","volume":"34","author":"Seger","year":"2010","journal-title":"J. Lab. Med."},{"key":"10.1016\/j.chroma.2023.463787_bib0018","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1200\/JCO.2012.43.5362","article-title":"Evidence for therapeutic drug monitoring of targeted anticancer therapies","volume":"30","author":"Gao","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.chroma.2023.463787_bib0019","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4155\/bio-2016-0068","article-title":"Bioanalysis of alectinib and metabolite M4 in human plasma, cross-validation and impact on PK assessment","volume":"8","author":"Heinig","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2023.463787_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/LSENS.2021.3106828","article-title":"Point-of-care 3-D printed spectrophotometer for therapeutic drug monitoring in tuberculosis patients","volume":"5","author":"Hooda","year":"2021","journal-title":"IEEE Sens. Lett."},{"key":"10.1016\/j.chroma.2023.463787_bib0021","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/10408363.2020.1774493","article-title":"What the lab can and cannot do: clinical interpretation of drug testing results","volume":"57","author":"Kapur","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.chroma.2023.463787_bib0022","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1556\/1326.2019.00578","article-title":"An HPLC-PDA method for determination of alectinib concentrations in the plasma of an adolescent","volume":"32","author":"Lee","year":"2020","journal-title":"Acta Chromatogr"},{"key":"10.1016\/j.chroma.2023.463787_bib0023","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpba.2018.08.038","article-title":"Bioanalytical liquid chromatography-tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates","volume":"161","author":"Sparidans","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2023.463787_bib0024","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jpba.2019.06.034","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry assay for nine oral anticancer drugs in human plasma","volume":"174","author":"Janssen","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2023.463787_bib0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jpba.2016.10.010","article-title":"An UPLC-MS\/MS method for the quantitation of alectinib in rat plasma","volume":"132","author":"Huang","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2023.463787_bib0026","doi-asserted-by":"crossref","first-page":"e00354","DOI":"10.1016\/j.heliyon.2017.e00354","article-title":"Metabolites of alectinib in human: their identification and pharmacological activity","volume":"3","author":"Sato-Nakai","year":"2017","journal-title":"Heliyon"},{"key":"10.1016\/j.chroma.2023.463787_bib0027","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/07373937.2011.645413","article-title":"Past, present, and future of solid phase extraction: a review","volume":"42","author":"Buszewski","year":"2012","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.chroma.2023.463787_bib0028","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.trac.2015.08.014","article-title":"Solid-phase extraction of organic compounds: a critical review","volume":"80","author":"Andradeeiroa","year":"2016","journal-title":"TrAC, Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2023.463787_bib0029","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/157341206776819346","article-title":"Solid-phase extraction (SPE) techniques for sample preparation in clinical and pharmaceutical analysis: a brief overview","volume":"2","author":"Li","year":"2006","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.chroma.2023.463787_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chroma.2019.04.014","article-title":"Synthesis and characterization of polyamide-graphene oxide-polypyrrole electrospun nanofibers for spin-column micro solid phase extraction of parabens in milk samples","volume":"1599","author":"Seidi","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.463787_bib0031","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.chroma.2017.03.026","article-title":"An immobilized titanium (IV) ion affinity chromatography adsorbent for solid phase extraction of phosphopeptides for phosphoproteome analysis","volume":"1498","author":"Yao","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.463787_bib0032","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.aca.2016.11.009","article-title":"Molecularly imprinted phloroglucinol-formaldehyde-melamine resin prepared in a deep eutectic solvent for selective recognition of clorprenaline and bambuterol in urine","volume":"951","author":"Liang","year":"2017","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.chroma.2023.463787_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461214","article-title":"One pot green synthesis of m-aminophenol-urea-glyoxal resin as pipette tip solid-phase extraction adsorbent for simultaneous determination of four plant hormones in watermelon juice","volume":"1623","author":"Lu","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.463787_bib0034","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1039\/D1GC00789K","article-title":"A simple and benign protocol for the synthesis of deep eutectic solvents-based hydrophilic molecularly imprinted resin in water for excellent selective molecular recognition in aqueous phase","volume":"23","author":"Wang","year":"2021","journal-title":"Green Chem"},{"key":"10.1016\/j.chroma.2023.463787_bib0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.talanta.2014.12.032","article-title":"Preparation of molecularly imprinted polymer with double templates for rapid simultaneous determination of melamine and dicyandiamide in dairy products","volume":"134","author":"Liu","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.chroma.2023.463787_bib0036","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1039\/b804716b","article-title":"One-step hydrothermal synthesis of ordered mesostructured carbonaceous monoliths with hierarchical porosities","volume":"23","author":"Huang","year":"2008","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chroma.2023.463787_bib0037","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4155\/bio-2016-0284","article-title":"LC\u2013MS\/MS determination of alectinib and its major human metabolite M4 in human urine: prevention of nonspecific binding","volume":"9","author":"Heinig","year":"2017","journal-title":"Bioanalysis"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967323000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967323000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T06:20:05Z","timestamp":1758262805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967323000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":37,"alternative-id":["S0021967323000158"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2023.463787","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Honeycomb resin-based spin-column solid-phase extraction for efficient determination of alectinib and its metabolite in human urine","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2023.463787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"463787"}}